Meanwhile, a treatment with ZERO SAE's in over 800 HIV

New Post Public Reply Private Reply Replies (2) Message Board
Cycl2R dejavu #35732
652
Meanwhile, a treatment with ZERO SAE's in over 800 HIV patients, over 5 years, cannot get a compassionate use designation.

Read More: https://investorshangout.com/post/view?id=577...z6Njf44Tna


And isn't it touching that the same "best people"--who had accepted remdesivir as a "new standard of care" and didn't say a word when the HQ was announced as the solution to Covid-19--finally got religion and now cared only about "science"? To the extent that they "recommended" Cytodyn against applying for compassionate use BECAUSE it could slow down our enrollments and be detrimental to the progress medical science! When I first heard about this from Dr. Pourhassan I felt ashamed because of my cynicism about the FDA and my silly (to say the least!) "conspiracy theories" about our democratically elected leaders and their appointees. But then I asked myself again: Why Dr. Lalezari sounded so pissed off with the FDA when they twice rejected his request for Compassionate Use back in early April. I also asked myself what happened to the rest of those 400 sick people who were screened by Novant and were denied participation in the trials because they apparently did not satisfy all "scientific" parameters of the studies? How did they do, those 380 or so? Now in the light of these questions I am no longer sure I must be ashamed of my suspicions about the "best people." Perhaps, I got to go back to square one of my thinking about them-- the imperative of deniability. If the FDA granted us the compassionate use, this would immediately and significantly increase our visibility and hopes for the cure. If the FDA formally denied our request this could raise questions later, especially in the scenario of leronlimab's eventual success and recognition. This is a no-no for the principle of deniability. So instead they gave us a friendly advice not apply for compassionate use ... for the sake of "science" and our best interests. Off the record. With the best intentions of the "best people."
1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beemo, Choreo Forge AI Partnership for Wealth Management

Updated Category News Views 9

AI's New Role in Wealth Management Just when you think you've seen it all, along comes a partnership that shakes things up. Beemo Automation is teaming up with Choreo, a heavyweight in the tax-focused registered investment adviser world, to infuse some AI prowess where it matters. Choreographing their moves, they're looking to build something that's not just functional...

Continue Reading
Saudi Arabia Unveils CEER's Flagship Electric Vehicles

Updated Category News Views 4

CEER's Ambitious Leap in Automotive Innovation There's a new kid on the automotive block, and it's making some serious noise. Straight out of Jeddah, CEER has just taken the wraps off their flagship electric sedan and SUV, dubbed the EXOBOT. No small beans here—this is a full-throttle, Saudi-driven pitch into the global automotive circus. And why not? There's oil in...

Continue Reading
ViewScan Unveils New AI Solution and Enhanced Site

Updated Category News Views 3

ViewScan's Latest Step in AI-Powered Monitoring Long Island's own ViewScan just kicked up some dust in the AI-based monitoring scene. This outfit is rolling out a new release of its ViewScan Protect software, fortified with advanced analytics aimed at beefing up security and operational efficiency. Now, before you gloss over this news as just another tech update, let me...

Continue Reading
iFranchise Holds Top Spot in Consulting for 8 Years

Updated Category News Views 4

iFranchise's Unyielding Dominance in Franchise Consulting Five seconds in the franchise game, and you'd know that staying on top is a grind. But when you're iFranchise Group, it seems like the eighth time is the charm—if there ever was a need for luck. These folks have secured the number one spot in Entrepreneur magazine's Top Franchise Suppliers ranking yet again....

Continue Reading
Holland America Overhauls Half Moon Cay Offerings

Updated Category News Views 4

A Fresh Chapter for Half Moon Cay Mark it down, folks—Holland America Line is shaking things up over at RelaxAway, Half Moon Cay. The cruise line, known for its deep roots in premium cruising, is pouring resources into its private island playground to celebrate its 30th anniversary in 2027. And the timing couldn't be more calculated, what with peak cruise season around...

Continue Reading
ScriptSafe Revolutionizes Pharmacy Payment & Ad Certification

Updated Category News Views 4

Pharmacy Certification Made Easy When ScriptSafe rolled out its certification service for pharmacies, it felt like the industry's straitjacket was finally coming off. We’re talking about a process that traditionally took months, cost a small fortune, and made pharmacies fill out forms like they were honing a doctoral thesis. But now, you've got ScriptSafe offering a...

Continue Reading
Aranscia Joins Northside Hospital in Precision Oncology

Updated Category News Views 6

Unifying Molecular Diagnostics for Better Cancer Care In the chaos of today’s healthcare, Aranscia is aiming to rewrite the book on how we handle cancer diagnostics by teaming up with Northside Hospital Cancer Institute. Now, instead of fumbling through disconnected systems, they plan to glue the pieces together with a blend of their own and borrowed tech. This...

Continue Reading
Matchi Debuts Protein-Packed Matcha Lattes in Cans

Updated Category News Views 4

A New Twist on Protein Beverages Today, Matchi Global LLC is rolling out something new and bold: canned protein matcha lattes. It's not just another protein shake disguised in green robes. Oh no, this is a straight-up attempt to mesh pure ceremonial-grade matcha with a full 20 grams of complete filtered milk protein. And they’re delivering it all without any of those...

Continue Reading
GRAI's Innovative Play with Hangout FM in Streaming

Updated Category News Views 4

Reimagining Streaming: GRAI Buys Hangout FM The music streaming game has just been dealt a fresh hand. GRAI, an AI-driven music company, has snatched up Hangout FM, looking to ignite a social revolution in how we experience music. Sitting here, I'm thinking about all those playlists we've built but never truly shared. This acquisition might just change that by combining...

Continue Reading
Dr. Sarah Leary Leads CBTN's Growth in Pediatric Oncology

Updated Category News Views 3

Pioneering Leadership for Children's Brain Tumor Network In a world where every advance in pediatric oncology can make a measurable difference, the Children's Brain Tumor Network (CBTN) has just unveiled quite the ace up its sleeve: Dr. Sarah Leary. She's stepping in as Co-Chair of its Executive Board, taking the reins alongside Brian Rood, MD. With extensive experience...

Continue Reading

Top 5 Most Recently Viewed Articles

Pfizer Inc. Faces Investigation into Board's Responsibilities

Updated Category News Views 137

Investigating Pfizer Inc.'s Board of Directors PHILADELPHIA — An investigation is underway focused on the Board of Directors of Pfizer Inc. (NYSE: PFE). This arises from concerns regarding potential breaches of fiduciary duties in relation to the marketing and sale practices of Depo-Provera, a well-known injectable form of contraception as well as a treatment for...

Continue Reading
Exciting Updates on DISC-0974 for Chronic Kidney Disease Patients

Updated Category News Views 77

Overview of DISC-0974 Presentation Disc Medicine, Inc., a pioneering biopharmaceutical company, has made significant strides in the development of innovative treatments for hematologic diseases. They recently announced that new clinical data will be showcased at the upcoming American Society of Nephrology (ASN) Kidney Week, highlighting the promising drug DISC-0974....

Continue Reading
Semler Scientific (NASDAQ: SMLR) Financial Results and Strategy Overview

Updated Category News Views 154

Semler Scientific Plans Future Growth and Financial Position In an exciting new phase for Semler Scientific, Inc. (NASDAQ: SMLR), the company is navigating significant changes in the financial landscape. Semler Scientific, a trailblazer in medical devices and software designed to address chronic diseases, is preparing to share its third quarter financial results. However,...

Continue Reading
Transforming Marketing with RAD Intel's Innovative Insights

Updated Category News Views 46

Introduction to RAD Intel's New Functionality In the fast-paced world of digital marketing, staying ahead of the curve is paramount. RAD Intel has recently enhanced its platform by introducing state-by-state functionality, which offers brands and agencies precise localized marketing insights. This new feature is designed to empower marketers with detailed data that helps...

Continue Reading
Navigating the Complex Landscape of Datavault AI and IBM

Updated Category News Views 181

Understanding Datavault AI’s Current Position Datavault AI Inc (NASDAQ: DVLT) recently encountered a bearish technical signal while simultaneously experiencing a surge in business momentum. This juxtaposition raises questions about the future trajectory of the company. Despite hitting a recent death cross in stock trading—an indicator typically seen as a sign of...

Continue Reading